|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$70,711.92 |
3.37% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$67,299.30 |
3.21% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$60,261.70 |
2.87% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$53,212.38 |
2.54% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$52,691.67 |
2.51% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$48,779.61 |
2.33% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$48,396.60 |
2.31% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$48,002.49 |
2.29% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$47,359.74 |
2.26% |
| Waters Corporation |
WAT |
941848103 |
148 |
$47,268.24 |
2.25% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$47,031.49 |
2.24% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$46,826.43 |
2.23% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$46,607.33 |
2.22% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$46,460.70 |
2.22% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$44,939.16 |
2.14% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,387.04 |
2.12% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$44,436.12 |
2.12% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$44,442.22 |
2.12% |
| Steris Plc |
STE |
G8473T100 |
169 |
$42,647.15 |
2.03% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$42,367.39 |
2.02% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$42,362.02 |
2.02% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$42,233.14 |
2.01% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$41,827.21 |
1.99% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$41,496.08 |
1.98% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$41,443.24 |
1.98% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$40,821.88 |
1.95% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$40,768.04 |
1.94% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$39,808.56 |
1.90% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$39,604.36 |
1.89% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$38,975.90 |
1.86% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$38,602.20 |
1.84% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$38,659.68 |
1.84% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$37,766.72 |
1.80% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,670.22 |
1.80% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$37,310.96 |
1.78% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$37,012.29 |
1.77% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$36,288.05 |
1.73% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$36,298.83 |
1.73% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$35,442.96 |
1.69% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$35,448.00 |
1.69% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$35,136.18 |
1.68% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$35,021.35 |
1.67% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$35,112.92 |
1.67% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$33,237.93 |
1.59% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$32,123.30 |
1.53% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$31,701.85 |
1.51% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$31,319.47 |
1.49% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$30,449.40 |
1.45% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$30,483.45 |
1.45% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$25,796.19 |
1.23% |
| US Dollar |
$USD |
|
2,649 |
$2,649.15 |
0.13% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|